Frontiers Update of Individualized Treatment Strategies for Postural Orthostatic Tachycardia Syndrome in Children

PDF) Predicting Therapeutic Efficacy of Pharmacological Treatments in Children with Postural Orthostatic Tachycardia Syndrome: A Mini-Review

5 Heritable Disorders of Connective Tissue and Effects on Function, Selected Heritable Disorders of Connective Tissue and Disability

Midregional Pro-Adrenomedullin as a Predictor for Therapeutic Response to Midodrine Hydrochloride in Children With Postural Orthostatic Tachycardia Syndrome

Frontiers Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies

Understanding Postural Orthostatic Tachycardia Syndrome (POTS): An Overview and Practical Advice

Autism and Health Issues Unpacked: Exploring the Intersection of Autism and Chronic Fatigue Syndrome

Postural orthostatic tachycardia syndrome (POTS) - List of Frontiers' open access articles

Experimental Therapeutics: Opportunities and Challenges Stemming From the National Institute of Mental Health Workshop on Novel Target Discovery and Psychosocial Intervention Development - Nancy L. Zucker, Gregory P. Strauss, Joshua M. Smyth

Table 2 from Clinical presentation and management of patients with hyperadrenergic postural orthostatic tachycardia syndrome. A single center experience.

Current treatments in familial dysautonomia. - Abstract - Europe PMC

Summary of treatment options existing for POTS with the corresponding

Standing Up to POTS on X: There is currently no cure for postural orthostatic tachycardia syndrome (POTS). There are no FDA approved medications. Most medications control individual symptoms, but not the underlying

Frontiers Update of Individualized Treatment Strategies for

Article: Postural orthostatic tachycardia syndrome (POTS): a

Dysautonomia, POTS Syndrome: Diagnosis, symptoms, treatment